This study disclosed the observation that the non-responder NHL patients have a significant upregulation in IL-4, IL-6, IL-10, IL-1β, VEGF, M-CSF expression level with minimum changes in IL-13 and IFN-γ levels. The gene discussed is IL13; the disease is non-Hodgkin lymphoma.